Anadrol and Exemestane Interaction

Avoid
Mechanism-based 75% confidence

Anadrol and Exemestane have a potentially harmful interaction with 75% confidence. Both Anadrol and Exemestane carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. Both compounds affect the gonads and liver and heart, so monitoring these systems is recommended.

Compound Profiles

Anadrol

Oral Anabolic Steroid | Extreme Mass & Strength

Oxymetholone exerts its effects primarily through binding to the androgen receptor (AR) to promote protein synthesis and nitrogen retention in skeletal muscle. As a DHT derivative, it cannot be converted to estrogen by the aromatase enzyme.

Half-life: ~8-9 hours Typical dose: 25-50 mg/day anabolic
androgen receptoraromataseepo receptorestrogen receptor androgenicaromatase inhibitorblood pressure raisingcarcinogenic risk
View full profile

Exemestane

Steroidal Aromatase Inhibitor | Irreversible Estrogen Control

Exemestane functions as a mechanism-based (suicide) inhibitor of aromatase (cytochrome P450 19A1). Due to its steroidal structure, exemestane is recognized by aromatase as a substrate analogue and enters the enzyme's active site.

Half-life: ~24 hours Typical dose: 12.5mg EOD or 25mg E3D (estrogen management) pct, anabolic
androgen receptoraromatase androgenicaromatase inhibitorestrogenichepatotoxic
View full profile

Combined Organ Load

Gonads
elevated
Liver
elevated
Heart
moderate
Pituitary
low

Shared Safety Flags

2x 2 androgenic compounds (Anadrol, Exemestane). Additive androgenic load — increased risk of hair loss, acne, prostate effects.
2x 2 compounds share the aromatase-inhibitor safety flag (Anadrol, Exemestane). Monitor accordingly.
2x 2 estrogenic compounds (Anadrol, Exemestane). Combined estrogen elevation — monitor E2 and consider aromatase inhibitor.
2x 2 hepatotoxic compounds (Anadrol, Exemestane). Liver damage risk significantly increased. Include liver support (TUDCA/NAC) and monitor ALT/AST.
2x 2 HPTA-suppressive compounds (Anadrol, Exemestane). Deep hormonal shutdown expected — plan extended PCT.
2x 2 compounds disrupt lipids (Anadrol, Exemestane). Get lipid panel mid-cycle — consider adding lipid support.
2x 2 compounds share the teratogenic safety flag (Anadrol, Exemestane). Monitor accordingly.

Frequently Asked Questions

Can I take Anadrol with Exemestane?

Combining Anadrol with Exemestane is not recommended. Both Anadrol and Exemestane carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently.

Is Anadrol and Exemestane safe together?

This combination carries significant risk. Both Anadrol and Exemestane carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. Consult a healthcare professional before combining.

What are the interactions between Anadrol and Exemestane?

Both Anadrol and Exemestane carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. This assessment has 75% confidence and is inferred from pharmacological mechanism analysis.

How should I time Anadrol and Exemestane?

Anadrol has a half-life of ~8-9 hours and Exemestane has a half-life of ~24 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Anadrol vs Exemestane

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.